• 1. Phosphotriester approach to the synthesis of oligonucleotides: a reappraisal
  Colin B. Reese,Zhang Pei-Zhuo J. Chem. Soc. Perkin Trans. 1 1993 2291

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Imidazoles Substituted imidazoles

Professional Introduction to 1-methyl-2-cyanoimidazole (CAS No. 45515-45-5)

1-methyl-2-cyanoimidazole (CAS No. 45515-45-5) is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research due to its versatile structural framework and potential biological activities. This compound, characterized by a cyano group and a methyl substituent on an imidazole ring, serves as a valuable scaffold for the development of novel therapeutic agents.

The imidazole core is a prominent motif in bioactive molecules, frequently observed in natural products and pharmacologically relevant compounds. Its unique electronic properties and ability to form hydrogen bonds make it an attractive component in drug design. The introduction of a cyano group at the 2-position and a methyl group at the 1-position further enhances its chemical diversity, enabling various functionalization strategies that can modulate its biological effects.

In recent years, there has been a surge in research focused on developing small-molecule inhibitors targeting specific enzymatic pathways involved in diseases such as cancer, inflammation, and neurodegeneration. 1-methyl-2-cyanoimidazole has emerged as a promising candidate in this context due to its ability to interact with biological targets in multiple ways. For instance, the cyano group can act as a hydrogen bond acceptor or participate in metal coordination, while the methyl group can influence the compound's lipophilicity and binding affinity.

One of the most compelling aspects of 1-methyl-2-cyanoimidazole is its potential application in the synthesis of kinase inhibitors. Kinases are enzymes that play a crucial role in cell signaling pathways, and their dysregulation is often associated with various diseases, particularly cancer. Researchers have reported the use of imidazole derivatives as scaffolds for designing kinase inhibitors, leveraging the inherent binding properties of the imidazole ring. The presence of additional functional groups like the cyano and methyl substituents allows for fine-tuning of the compound's interactions with the target kinase, leading to improved potency and selectivity.

Moreover, 1-methyl-2-cyanoimidazole has shown promise in preclinical studies as an anti-inflammatory agent. Inflammation is a complex biological response that involves numerous cellular pathways and mediators. The compound's ability to modulate key inflammatory cytokines and enzymes has been explored in several models, suggesting its potential as a therapeutic intervention. This aligns with the growing interest in developing anti-inflammatory drugs that target specific pathways without causing systemic side effects.

The synthesis of 1-methyl-2-cyanoimidazole typically involves multi-step organic reactions that require precise control over reaction conditions to ensure high yield and purity. Common synthetic routes include condensation reactions between appropriate precursors followed by functional group transformations such as nitrile formation and alkylation. Advances in synthetic methodologies have enabled more efficient and scalable production processes, making it feasible to conduct large-scale investigations into its biological properties.

In addition to its pharmaceutical applications, 1-methyl-2-cyanoimidazole has found utility in materials science and chemical biology. Its unique structural features make it suitable for designing probes and inhibitors for studying protein-protein interactions and enzyme mechanisms. The compound's ability to act as a ligand for metal ions also opens up possibilities for applications in catalysis and material design.

The growing body of research on 1-methyl-2-cyanoimidazole underscores its significance as a versatile building block in drug discovery and chemical innovation. As our understanding of biological systems continues to expand, compounds like this are likely to play an increasingly important role in developing next-generation therapeutics that address unmet medical needs.

• 79080-37-8(1H-Imidazole-2-carbonitrile,1,5-dimethyl-)
• 404354-85-4(Lithium, [(1-methyl-1H-imidazol-2-yl)methyl]-)
• 79080-36-7(1H-Imidazole-2-carbonitrile,1,4-dimethyl-)
• 64678-68-8(1H-Imidazole,2-methyl-1-(methyl-d3)- (9CI))
• 771540-84-2(1H-Imidazol-5-yl, 1,2-dimethyl-)
• 1506077-40-2(1-(Difluoromethyl)-1H-imidazole-2-carbonitrile)
• 35296-79-8(1H-Imidazole, dimethyl-)
• 1739-84-0(1H-imidazole, 1,2-dimethyl-)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)